Mineralocorticoid receptor antagonist use in eligible patients following acute myocardial infarction: Real world data from the Acute Coronary Syndrome Israeli Surveys: 2004–2010

Acute Coronary Syndrome ◽

Receptor Antagonist ◽

Real World ◽

Real World Data ◽

Mineralocorticoid Receptor Antagonist ◽

World Data ◽

Predictors of mineralocorticoid receptor antagonist utilization in patients with left ventricular dysfunction following acute myocardial infarction: real world data from the acute coronary syndrome IS

European Heart Journal ◽

10.1093/eurheartj/eht308.p1336 ◽

2013 ◽

Vol 34 (suppl 1) ◽

pp. P1336-P1336

Author(s):

E. Koifman ◽

E. Kopel ◽

G. Rozen ◽

E. Maor ◽

P. Fefer ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Real World ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Real World Data ◽

Mineralocorticoid Receptor Antagonist ◽

Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-019-00339-3 ◽

2019 ◽

Vol 19 (4) ◽

pp. 381-391 ◽

Cited By ~ 6

Author(s):

Ovidio De Filippo ◽

Martina Cortese ◽

Fabrizio D´Ascenzo ◽

Sergio Raposeiras-Roubin ◽

Emad Abu-Assi ◽

...

Keyword(s):

Myocardial Infarction ◽

Real World ◽

Real World Data ◽

World Data

Beneficial effects of direct call to emergency medical services on time delays and management of patients with acute myocardial infarction: Real world data from RICO database

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)81065-3 ◽

2003 ◽

Vol 41 (6) ◽

pp. 376-377

Author(s):

Jean-Claude Beer ◽

Gilles Dentan ◽

Luc Janin-Manificat ◽

Marianne Zeller ◽

Yves Laurent ◽

...

Keyword(s):

Myocardial Infarction ◽

Emergency Medical Services ◽

Real World ◽

Time Delays ◽

Medical Services ◽

Real World Data ◽

World Data ◽

Beneficial Effects ◽

Emergency Medical

P6028Antiplatelet therapy in acute coronary syndrome associated with renal impairment. Real world data

European Heart Journal ◽

10.1093/eurheartj/ehy566.p6028 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

A Izquierdo Bajo ◽

M Almendro Delia ◽

T Seoane-Garcia ◽

L Madrona Jimenez ◽

M Garcia Del Rio ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Renal Impairment ◽

Real World ◽

Real World Data ◽

World Data ◽

PCV44 COST-EFFECTIVENESS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF REAL WORLD DATA

Value in Health ◽

10.1016/j.jval.2019.04.480 ◽

2019 ◽

Vol 22 ◽

pp. S126-S127

Author(s):

T.H. Hsieh ◽

C.Y. Shih ◽

P.Y. Liu ◽

J.S. Hwang ◽

J.D. Wang

Keyword(s):

Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Cost Effectiveness ◽

Real World ◽

Coronary Intervention ◽

Real World Data ◽

World Data ◽

Percutaneous Coronary

PDG108 CLINICAL OUTCOMES ON SWITCHING BETWEEN NEWER P2Y12 RECEPTOR INHIBITORS AND CLOPIDOGREL IN DUAL ANTIPLATELET THERAPY IN HONG KONG ACUTE CORONARY SYNDROME POPULATION USING REAL WORLD DATA

Value in Health ◽

10.1016/j.jval.2019.09.1121 ◽

2019 ◽

Vol 22 ◽

pp. S614-S615

Author(s):

A. Lam ◽

B. Yan ◽

V. Lee

Keyword(s):

Acute Coronary Syndrome ◽

Hong Kong ◽

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Real World ◽

Dual Antiplatelet Therapy ◽

P2y12 Receptor ◽

Real World Data ◽

World Data ◽

Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-019-00351-7 ◽

2019 ◽

Vol 19 (4) ◽

pp. 429-429

Author(s):

Ovidio De Fillippo ◽

Martina Cortese ◽

Fabrizio D´Ascenzo ◽

Sergio Raposeiras-Roubin ◽

Emad Abu-Assi ◽

...

Keyword(s):

Myocardial Infarction ◽

Real World ◽

Real World Data ◽

World Data

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

Clinical Research in Cardiology ◽

10.1007/s00392-019-01500-3 ◽

2019 ◽

Vol 109 (2) ◽

pp. 194-204 ◽

Cited By ~ 8

Author(s):

Susan Stienen ◽

Patrick Rossignol ◽

António Barros ◽

Nicolas Girerd ◽

Bertram Pitt ◽

...

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Receptor Antagonist ◽

Fibrotic Response ◽

Mineralocorticoid Receptor Antagonist ◽

Antagonist Therapy ◽

St Elevation ◽

Infarction Heart

Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction

Folia Pharmacologica Japonica ◽

10.1254/fpj.124.90 ◽

2004 ◽

Vol 124 (2) ◽

pp. 90-100 ◽

Cited By ~ 1

Author(s):

Takayoshi TSUTAMOTO

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Congestive Heart Failure ◽

Receptor Antagonist ◽

Mineralocorticoid Receptor Antagonist

Ventricular Remodeling ◽

Left Ventricular Remodeling ◽

Left Ventricular ◽

A Comparative Study of High-Intensity Rosuvastatin versus Atorvastatin Therapy Post-Acute Coronary Syndrome Using Real-World Data

Current Problems in Cardiology ◽

10.1016/j.cpcardiol.2021.100956 ◽

2021 ◽

pp. 100956

Author(s):

Alaa Rahhal ◽

Fadi Khir ◽

Bassant Orabi ◽

Salma Chbib ◽

Osama Al-Khalaila ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Comparative Study ◽

Real World ◽

High Intensity ◽

Real World Data ◽

World Data ◽

Coronary Syndrome ◽

Atorvastatin Therapy